Stocks CGNT Financial statements
Financial statementsCognyte Software Ltd. financial statements
Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data Cognyte Software Ltd. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2020 | FY2020 | FY2020 | FY2021 | FY2022 | FY2023 | FY2025 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 433 | 457 | 443 | 474 | 312 | 313 | 351 | 400 |
| Cost of revenue | 177 | 164 | 133 | 132 | 120 | 98 | 104 | 110 |
| Gross profit | 257 | 293 | 311 | 342 | 192 | 215 | 247 | 290 |
| Research and development | 100 | 111 | 129 | 143 | 140 | 107 | 108 | 122 |
| Selling, general and administrative | 137 | 154 | 163 | 186 | 154 | 126 | 144 | 154 |
| Selling and marketing | 101 | 81.6 | 95 | 107 | ||||
| General and administrative | 53.3 | 44.2 | 48.5 | 47.1 | ||||
| Operating expenses | 238 | 266 | 293 | 331 | 295 | 233 | 252 | 276 |
| Operating income | 18.7 | 27.3 | 18.3 | 11 | -103 | -18.1 | -5.13 | 13.3 |
| Interest expense | 0.5 | 0.48 | 0.19 | 0.2 | 1.6 | 0.02 | 0.1 | 0.19 |
| Interest income | 3.17 | 3.51 | 1.35 | 0.18 | 0.77 | 1.9 | 2.47 | 2.03 |
| Other non-operating income | 1.25 | 2.62 | 6.45 | -2.7 | 6.33 | 4.8 | 0.76 | -1.92 |
| Pre-tax income | 19.9 | 29.9 | 24.7 | 8.26 | -97 | -13.3 | -4.37 | 11.3 |
| Income tax | 7.62 | 2.57 | 4.41 | 18.5 | 13 | -1.61 | 2.86 | 6.73 |
| Net income to minority interests | 3.59 | 7.18 | 6.11 | 4.63 | 4.18 | 3.93 | 4.82 | 5.25 |
| Net income | 8.73 | 20.2 | 14.2 | -14.9 | -114 | -15.6 | -12.1 | -0.64 |
| EBITDA | 39.7 | 44.6 | 40.8 | 32.2 | -85.3 | -4.24 | 8.53 | 25.2 |
| EPS, basic | 0.13 | 0.31 | 0.22 | -0.22 | -1.68 | -0.22 | -0.17 | -0.01 |
| EPS, diluted | 0.13 | 0.31 | 0.22 | -0.22 | -1.68 | -0.22 | -0.17 | -0.01 |
| Shares, basic (weighted) | 65.8 | 65.8 | 65.8 | 66.6 | 67.9 | 70.1 | 71.8 | 72.9 |
| Shares, diluted (weighted) | 65.8 | 65.8 | 65.8 | 66.6 | 67.9 | 70.1 | 71.8 | 72.9 |
Balance sheet
| FY2020 | FY2020 | FY2020 | FY2021 | FY2022 | FY2023 | FY2025 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 240 | 201 | 78.6 | 153 | 34.6 | 74.5 | 113 | 117 |
| Short-term investments | 6.6 | 4.71 | 10.4 | 17.5 | 0 | |||
| Receivables | 180 | 175 | 179 | 113 | 113 | 109 | 123 | |
| Inventory | 14.9 | 14.5 | 14.4 | 25.3 | 24.6 | 19 | 16.4 | |
| Other current assets | 3.48 | 2.07 | 0.76 | 0.6 | 0.94 | 0.81 | 0.83 | |
| Total current assets | 512 | 350 | 420 | 252 | 265 | 286 | 298 | |
| Property, plant and equipment | 41.6 | 37.6 | 30.8 | 25.9 | 24.4 | 28.3 | 29.1 | |
| Lease right-of-use assets | 34.2 | 32.1 | 25 | 17.6 | 33.8 | 35.2 | 40.4 | |
| Goodwill | 147 | 158 | 158 | 158 | 126 | 127 | 126 | 127 |
| Intangible assets | 7.87 | 5.3 | 3.16 | 0.65 | 0.26 | 0 | 4.38 | |
| Other non-current assets | 49.2 | 42.1 | 25.7 | 20 | 19.1 | 18.9 | 16.2 | |
| Total assets | 805 | 629 | 665 | 443 | 472 | 498 | 521 | |
| Accounts payable | 43.4 | 41.6 | 36.7 | 20.7 | 20.9 | 25.2 | 26.9 | |
| Accrued liabilities | 85.9 | 91.7 | 99.8 | 78.3 | 75.8 | 86.7 | 94.6 | |
| Deferred revenue | 144 | 127 | 83.2 | 94.9 | 93.8 | 107 | 103 | |
| Short-term debt | 0 | 100 | 0 | |||||
| Total current liabilities | 280 | 299 | 320 | 194 | 190 | 219 | 224 | |
| Lease liabilities | 24.4 | 24.1 | 17.2 | 10.4 | 28 | 29.8 | 36.5 | |
| Other non-current liabilities | 17.4 | 9.2 | 10.8 | 11.7 | 7.61 | 7.68 | 9.37 | |
| Total liabilities | 350 | 358 | 366 | 233 | 257 | 281 | 292 | |
| Paid-in capital | 0 | 317 | 338 | 355 | 374 | 395 | ||
| Retained earnings | 0 | -14.9 | -129 | -145 | -157 | -157 | ||
| Treasury stock | 0 | -5.28 | -26.7 | |||||
| Other comprehensive income | -13.9 | -15.5 | -16.7 | -15.3 | -12.6 | -14 | -4.84 | |
| Shareholders' equity | 445 | 258 | 285 | 194 | 198 | 198 | 207 | |
| Minority interests | 10.6 | 12.9 | 14 | 15.6 | 16.9 | 18.9 | 22.3 | |
| Total equity | 475 | 455 | 270 | 299 | 210 | 215 | 217 | 229 |
| Total liabilities and equity | 805 | 629 | 665 | 443 | 472 | 498 | 521 | |
| Shares outstanding | 65.8 | 67.2 | 68.8 | 71 | 72.1 | 73.1 |
Cash flow statement
| FY2020 | FY2020 | FY2020 | FY2021 | FY2022 | FY2023 | FY2025 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Net income | 12.3 | 27.4 | 20.3 | -10.3 | -110 | -11.6 | -7.23 | 4.61 |
| Depreciation and amortization | 21 | 17.3 | 22.5 | 21.3 | 18.1 | 13.8 | 13.7 | 12 |
| Stock-based compensation | 25.5 | 31 | 27.4 | 32.9 | 25.2 | 12.2 | 19 | 21.2 |
| Deferred income tax | 9 | 5.6 | -2.2 | 5.86 | 0.05 | -3.2 | -1.36 | -1.96 |
| Change in receivables | -44.1 | -24.1 | 1.5 | -5.72 | 59.2 | 12.4 | 10.6 | -6.27 |
| Change in inventory | -3.62 | -0.39 | -1.14 | -0.36 | -13.1 | -0.96 | 4.57 | 2.42 |
| Change in payables | -7.75 | 1.31 | 8.67 | 4.89 | -37.9 | 4.33 | 14.3 | 10.5 |
| Cash from operations | 53.7 | 67.2 | 71.3 | 2.63 | -37 | 34.6 | 46.8 | 40.3 |
| Capital expenditures | -9.92 | -13.7 | -14.2 | -11.8 | -8.27 | -7.04 | -10.6 | -10.4 |
| Acquisitions | -3.81 | -18.7 | 0 | 0 | -4.28 | |||
| Purchases of investments | -57.7 | -29.1 | -48.6 | -59 | -55.2 | -58.7 | 0 | 0 |
| Cash from investing | -68.3 | -29.5 | 16.4 | -17.9 | 20.1 | 9.36 | -5.69 | -14.1 |
| Cash from financing | 6.06 | -86 | -206 | 58.7 | -103 | -2.45 | -7.95 | -24.8 |
| Exchange rate effect | -0.54 | -0.99 | -0.86 | 0.04 | 0.62 | -0.12 | -0.63 | 2.58 |
| Net change in cash | -9.09 | -49.3 | -119 | 43.6 | -119 | 41.4 | 32.5 | 3.97 |
| Free cash flow | 43.8 | 53.5 | 57.1 | -9.13 | -45.3 | 27.5 | 36.2 | 29.9 |
| Interest paid | 0.02 | 0.02 | 0.04 | 0.47 | 1.98 | 0.66 | 0.5 | 0.49 |
| Income taxes paid | 7.6 | 9.62 | 1.26 | 8.23 | 11.3 | 6.77 | 7.15 | 8.48 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 72.4% | Gross profit / revenue. |
| Operating margin | 3.3% | Operating income / revenue. |
| EBITDA margin | 6.3% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 2.8% | Pre-tax income / revenue. |
| Net margin | -0.2% | Net income / revenue. |
| FCF margin | 7.5% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 10.1% | Cash from operations / revenue. |
| Effective tax rate | 59.3% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | -0.3% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -0.1% | Net income / average total assets. |
| Return on invested capital (ROIC) | 12.0% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 30.6% | Research and development expense / revenue. |
| SG&A / revenue | 38.4% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 5.3% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 2.6% | Capital expenditures / revenue. |
| D&A / revenue | 3.0% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 14.1% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 8.6% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | -2.0% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 17.3% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 14.7% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | -1.4% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income CAGR, 5y | -6.2% | Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 196.0% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 5y | -9.2% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -13.8% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 5y | -10.8% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | -17.3% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 5y | -12.1% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | 4.2% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 2.1% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | -4.3% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 4.7% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 5.6% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | -3.7% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 1.6% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 2.4% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 2.1% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.33x | Current assets / current liabilities. |
| Quick ratio | 1.07x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.52x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 56.1% | Total liabilities / total assets. |
| Interest coverage | 68.4x | Operating income / interest expense. |
| Working capital | $74.2M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 25.1% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $75.6M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.79x | Revenue / average total assets. |
| Fixed asset turnover | 13.9x | Revenue / average property, plant and equipment. |
| Inventory turnover | 6.23x | Cost of revenue / average inventory. |
| Days inventory | 59 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 3.45x | Revenue / average receivables. |
| Days sales outstanding | 106 days | 365 x average receivables / revenue. |
| Days payables | 86 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 78 days | Days inventory + days sales outstanding - days payables. |
| Capex / operating cash flow | 25.8% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$0.01 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | -$0.01 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $5.49 | Revenue / diluted weighted shares. |
| FCF per share | $0.41 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $0.55 | Cash from operations / diluted weighted shares. |
| Book value per share | $2.83 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $1.03 | Tangible book value / shares outstanding. |
| Cash per share | $1.60 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $629.6M | Share price x shares outstanding. |
| Enterprise value | $512.8M | Market cap + total debt - cash - short-term investments. |
| P/S | 1.57x | Market cap / revenue. |
| P/B | 3.05x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 8.33x | Market cap / tangible book value, when positive. |
| P/FCF | 21.0x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 15.6x | Market cap / cash from operations, when positive. |
| EV/Sales | 1.28x | Enterprise value / revenue. |
| EV/EBIT | 38.7x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 20.3x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 17.1x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 4.8% | Free cash flow / market cap. |
| Earnings yield | -0.1% | Net income / market cap (the inverse of P/E). |
What was Cognyte Software Ltd.'s revenue in fiscal 2025?
Cognyte Software Ltd. reported revenue of $400.0M for fiscal 2025, 14.1% higher than the year before.
Was Cognyte Software Ltd. profitable in fiscal 2025?
No. It reported a net loss of $638.0K.
How much free cash flow did Cognyte Software Ltd. generate in fiscal 2025?
Cash from operations of $40.3M minus capital expenditures of $10.4M left free cash flow of $29.9M.